From Beth Lewin Dean, CEO <[email protected]>
Subject New FDA Alert for Lamotrigine
Date October 28, 2020 4:28 PM
  Links have been removed from this email. Learn more in the FAQ.
  Links have been removed from this email. Learn more in the FAQ.
A new FDA alert has been issued for Lamotrigine/Lamictal.

A new FDA alert has been issued for Lamotrigine/Lamictal. If you are taking this drug and have a cardiac condition, especially arrhythmia, there are new warnings, including the potential for sudden death. If you have concerns or questions about using this product, please call your doctor.

Please see the links below for more details:
* FDA Drug Alerts ([link removed])
* Lamotrigine Drug Warning Label ([link removed])

============================================================
** Twitter ([link removed])
** Facebook ([link removed])
** LinkedIn ([link removed]-)
** Instagram ([link removed])
** YouTube ([link removed])
Copyright © 2020 CURE Epilepsy, All rights reserved.
In the past you provided CURE Epilepsy your email address. Occasionally, you will receive updates from us about epilepsy research and news.

Our mailing address is:
CURE Epilepsy
420 Wabash Ave, Ste 650
Chicago, IL 60611
USA
Want to change how you receive these emails?
You can ** update your preferences ([link removed])
or ** unsubscribe from this list ([link removed])
.

This email was sent to [email protected] (mailto:[email protected])
why did I get this? ([link removed]) unsubscribe from this list ([link removed]) update subscription preferences ([link removed])
CURE Epilepsy . 420 Wabash Ave, Ste 650 . Chicago, IL 60611 . USA
Screenshot of the email generated on import

Message Analysis